MassDevice

Medtronic earns expanded FDA nod for deep brain stim

The medtech giant said the approval marks a shift from humanitarian device exemption (HDE) status to full effectiveness ...
Fierce Biotech

After more than 20 years, Medtronic claims deep brain stimulation approval for dystonia

In 2003, Medtronic first received a humanitarian green light from the FDA to offer its deep brain stimulation implants to ...
Medical News Today

What to know about dystonias, and how to treat them

Dystonias are neurological disorders that can cause jerky movements, muscle spasms, repetitive actions, and unusual and awkward postures. Dystonia is a type of involuntary movement, and people ...
Monthly Prescribing Reference

Single Psychedelic Dose Reduces Symptoms of Generalized Anxiety Disorder

However, the 25-μg and 50-μg dose groups did not reach significant differences vs placebo. HealthDay News — A single dose of a pharmaceutical formulation of LSD provides significant relief for ...
Hosted on MSN

Single Psychedelic Dose Reduces Symptoms of Generalized Anxiety Disorder

WEDNESDAY, Sept. 10, 2025 (HealthDay News) -- A single dose of a pharmaceutical formulation of LSD provides significant relief for patients with moderate-to-severe generalized anxiety disorder (GAD), ...
The Village Reporter

Toledo Dystonia Zoo Day To Focus On Rare Movement Disorder

PRESS RELEASE – The Toledo Dystonia Zoo Day will be held at the Toledo Zoo in Toledo on Saturday, August 23, 2025, serving as a family-friendly event to bring visibility to a rare movement disorder ...
WebMD

Generalized Pustular Psoriasis: Symptoms, Causes, Treatment

What Is Generalized Pustular Psoriasis? Generalized pustular psoriasis (GPP) is the rarest form of psoriasis, a chronic autoimmune skin condition. GPP can be severe, even life-threatening. The disease ...
SciELO

Cervical dystonia: about familial and sporadic cases in 88 patients

Cervical dystonia (CD) affects the musculature of the neck in a focal way or associated to other parts of the body. The aim of this study was to identify clinical differences between patients with ...
Morningstar

UPLIZNA® (INEBILIZUMAB-CDON) SIGNIFICANTLY IMPROVES GENERALIZED MYASTHENIA GRAVIS SYMPTOMS IN ACETYLCHOLINE RECEPTOR AUTOANTIBODY-POSITIVE PATIENTS ...

THOUSAND OAKS, Calif., March 13, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new data from the Phase 3, registrational MINT trial evaluating the efficacy and safety of UPLIZNA ® ...
Benzinga.com

Amgen's Uplizna Shows Improved Symptoms In Patients With Muscle Weakness Disorder Over One Year

On Thursday, Amgen Inc (NASDAQ:AMGN) announced new data from the Phase 3 MINT trial of Uplizna (inebilizumab-cdon) for adult patients with generalized myasthenia gravis (gMG), a chronic autoimmune ...
La Grande Observer

UPLIZNA® (INEBILIZUMAB-CDON) SIGNIFICANTLY IMPROVES GENERALIZED MYASTHENIA GRAVIS SYMPTOMS IN ACETYLCHOLINE RECEPTOR AUTOANTIBODY-POSITIVE PATIENTS ...

THOUSAND OAKS, Calif., March 13, 2025 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced new data from the Phase 3, registrational MINT trial evaluating the efficacy and safety of UPLIZNA ® ...